A 33 diverse cancer immune subtype classification has described the immune landscape of PCa according to the immune expression characteristics of four representative signatures: C1 (wound healing), C2 (IFN-γ dominant), C3 (inflammatory), and C4 (lymphocyte depleted) [19]. The gene discussed is IFNG; the disease is cancer.